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Abstract
The Epstein-Barr virus (EBV) is transmitted from host-to-host via saliva and is associated
with epithelial malignancies including nasopharyngeal carcinoma (NPC) and some forms of
gastric carcinoma (GC). Nevertheless, EBV does not transform epithelial cells in vitro
where it is rapidly lost from infected primary epithelial cells or epithelial tumor cells. Long-
term infection by EBV, however, can be established in hTERT-immortalized nasopharyn-
geal epithelial cells. Here, we hypothesized that increased telomerase activity in epithelial
cells enhances their susceptibility to infection by EBV. Using HONE-1, AGS and HEK293
cells we generated epithelial model cell lines with increased or suppressed telomerase ac-
tivity by stable ectopic expression of hTERT or of a catalytically inactive, dominant negative
hTERT mutant. Infection experiments with recombinant prototypic EBV (rB95.8), recombi-
nant NPC EBV (rM81) with increased epithelial cell tropism compared to B95.8, or recombi-
nant B95.8 EBV with BZLF1-knockout that is not able to undergo lytic replication, revealed
that infection frequencies positively correlate with telomerase activity in AGS cells but also
partly depend on the cellular background. AGS cells with increased telomerase activity
showed increased expression mainly of latent EBV genes, suggesting that increased telo-
merase activity directly acts on the EBV infection of epithelial cells by facilitating latent EBV
gene expression early upon virus inoculation. Thus, our results indicate that infection of epi-
thelial cells by EBV is a very selective process involving, among others, telomerase activity
and cellular background to allow for optimized host-to-host transmission via saliva.
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Introduction
Epstein-Barr virus (EBV) is transmitted via saliva and has to pass the oral mucosal epithelium
after exiting from B cells, the site where the virus establishes latency. The source of EBV infec-
tious progeny in saliva remains elusive [1–3]. It has been demonstrated that differentiation of
memory B cells into plasma cells results in reactivation of latent EBV and virus replication [4].
Nevertheless, EBV is believed to reside and replicate also in oropharyngeal epithelium [5,6].
Notably, cell-free EBV predominantly infects epithelial cells from the basolateral membranes
[7], and cell-associated virus efficiently infects cells from the apical surface [8] especially after
cell-to-cell contact [9]. Recent work has shown that cell-associated EBV infects in vitro recon-
stituted stratified epithelium from its mucosal surface [10]. Since EBV egressing from epithelial
cells is more lymphotropic than EBV egressing from B cells [11], lytic replication in oropharyn-
geal epithelial cells might be important for efficient host-to-host transmission.
The oral mucosal epithelium is a dynamic tissue with a distinct multilayer architecture [12].
Its basement membrane separates the epithelium from the underlying lamina propria and en-
sures correct and directed migration and differentiation of the overlying epithelial cells towards
the surface of the epithelium. The stratum basale, a single layer of cells resting on the basement
membrane, is most important for tissue hemostasis. The stratum basale harbors a small sub-
population of epithelial stem cells, which can undergo mitotic division and give rise to tran-
siently proliferating progenitor cells [12,13]. The transiently proliferating cells then can gener-
ate daughter cells that migrate and differentiate through the stratum spinosum and stratum
granulosum towards the epithelial surface, the stratum corneum. Epithelial stem cells have an
increased expression and activity of the human telomerase reverse transcriptase (hTERT), the
rate-limiting component of the telomerase complex, to ensure indefinite proliferation and con-
tinuous self-renewal capacity [13–17]. Since epithelial cells differ considerably depending on
their site of origin and differentiation stage and exhibit variable binding of EBV [7], the stable
infection of epithelial cells by EBV is likely to be a very selective process, linked among others
to the cell differentiation state.
EBV is associated with epithelial cell carcinomas including nasopharyngeal carcinoma
(NPC) and gastric carcinoma (GC) where the virus expresses latency genes [18]. In vitro, EBV
is rapidly lost from infected primary epithelial cells or from epithelial tumor cells [19–22].
Nonetheless, it is possible to establish hTERT-immortalized nasopharyngeal epithelial cell
clones that are able to support a long-term infection by EBV. It appears that loss or inactivation
of the tumor suppressor p16 and cyclin D1 overexpression are crucial events for the establish-
ment and the support of a stable EBV infection [23–25]. Both events are common in NPC and
GC development [26–30] and impact on telomerase activity [31]. Thus, cells with enhanced
survival potential seem to be more susceptible to EBV infection.
On the other hand, EBV itself has the ability to induce telomerase activity in B-cells [32–34]
through LMP1, the major EBV-encoded oncogene. Notably, LMP1 induces telomerase activity
viaNF-κB activation in B cells and after ectopic expression in epithelial cells [35–37]. Further-
more, LMP2A affects hedgehog signaling and induces stem cell behavior in epithelial cells [38]
and BARF1 may trigger expression of cyclin D1 in epithelial cells [39]. Therefore, upon entry
into epithelial cells and following expression of its main latency gene products, EBV may create
conditions for its own persistence and alter epithelial cell functions, provided that appropriate
signaling adapter molecules are present in the infected cell. This may be different in epithelial
cells from different origin and has received little attention thus far. Importantly, hTERT con-
tributes to EBV maintenance by induction of EBV latent gene expression and down-regulation
of lytic EBV gene expression in early-passage infected B lymphocytes [40]. Moreover, hTERT
inhibition might promote lytic EBV replication in EBV-immortalized and fully transformed B
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cells [41], thus providing a potential therapeutic target. Nevertheless, the impact of hTERT ex-
pression and telomerase activity on EBV infection in epithelial cells remains to be elucidated.
Here, we hypothesized that increased telomerase activity in epithelial cells can enhance their
susceptibility to infection by EBV. Thus, we generated epithelial model cell lines (i) with in-
creased telomerase activity, by ectopic expression of hTERT, and (ii) with lowered telomerase
activity, by ectopic expression of a catalytically inactive DNhTERT. Subsequently, we assessed
the EBV infection frequencies and virus transcriptional activity in the model cell lines after in-
oculation with three EBV strains: (i) the reference strain B95.8, (ii) M81 with increased tropism
for epithelial cells, and (iii) B95.8 with BZLF1 knockout that is impaired for lytic replication.
Material and Methods
Cells and Viruses
As epithelial model cell lines we used the nasopharyngeal carcinoma (NPC) cell line HONE-1
[20], maintained in RPMI-1640 (Sigma-Aldrich, Buchs, Switzerland), the gastric carcinoma
cell line AGS [42], maintained in HAM’s F-12 (Sigma-Aldrich) and the human embryonic kid-
ney cell line HEK293 [43], maintained in Dulbecco’s Modified Eagle’s Medium (DMEM;
Sigma-Aldrich). All media were supplemented with 10% heat inactivated Fetal Bovine Serum
(hiFBS; Sigma-Aldrich), 1% L-Glutamine and 1% Penicillin/Streptomycin (Gibco, Zug,
Switzerland).
Supernatant containing the recombinant EBV strain rM81 with more pronounced epithelial
cell tropism [44] was kindly provided by Prof. H.-J. Delecluse (DKFZ Heidelberg, Germany).
The EBV producer cell lines HEK293-rB95.8 [45], for the production of the prototypic EBV
strain B95.8 (rB95.8), and HEK293-rBZLF1-KO [46], for the production B95.8 virus with a
BZLF1-knockout (rBZLF1-KO) that is therefore not capable of lytic replication, were main-
tained in DMEM (Sigma-Aldrich) supplemented with 10% hiFBS, 1% L-Glutamine, 1% Peni-
cillin/Streptomycin, 100 μg/ml Hygromycin B (HygroGOLD; InvivoGen, Toulouse, France).
Virus-containing supernatants were produced as described elsewhere [47]. Briefly, 80–90%
confluent HEK293-rB95.8 cells were transfected with expression plasmids encoding the EBV
gene BZLF1, to induce lytic replication, and BALF4, to optimize gp110 levels on the viral sur-
face [48], (2 μg each/10 cm plate) using Metafectene (Biontex, Martinsried/Planegg, Germany).
Four hours after transfection, the transfection mixture was replaced by fresh supplemented
DMEM without Hygromycin B. Three to four days after transfection, supernatants were har-
vested, cleared by centrifugation at 4°C with 1.000 × g for 15 min, filtered through a 0.45 μm
filter and stored at -80°C. Concentrated virus stocks were prepared by centrifugation of viral
supernatant with 30.000 × g for 2.5 h at 4°C and resuspension of the virus pellet in 1x PBS (1/
100 of the starting Volume). The number of infectious EBV units was determined as described
elsewhere and virus titers are given as multiplicity of infection (MOI) and defined as infectious
units/target cell [47,49]. For the virus strains rM81 and rBZLF1-KO we additionally deter-
mined the amount of EBV genome equivalents/ml supernatant or concentrated virus by quan-
titative PCR using a LMP1-specific primer/probe set as described previously [50]. Virus
supernatants or concentrated virus stock were subjected to DNase treatment using the Ambion
DNAfree kit (Applied Biosystems, Zug, Switzerland) before DNA isolation to estimate the
amount of encapsidated viral genomes and therefore potentially infectious virus. The amount
of virus, used for the infections, was adjusted for each virus strain corresponding to the highest
MOI of 2.5 infectious units/target cell.
EBV in Epithelial Cells
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Generation of hTERT and DNhTERT overexpressing epithelial cell lines
To generate hTERT overexpressing cells we employed the expression vector pWZL-Blast-Flag-
HA-hTERT [51], kindly provided by William C. Hahn (Harvard Medical School, Cambridge,
MA, USA). To generate cells expressing the dominant negative hTERT mutant (DNhTERT)
we exchanged the hTERT insert from pWZL-Blast-Flag-HA-hTERT with the DNhTERT mu-
tant from the expression vector pBABE-DNhTERT [52], kindly provided by Robert Weinberg
(Whitehead Institute for Biomedical Research, Cambridge, MA, USA), using the EcoRI/SalI re-
striction sites. Empty control vector was generated by excision of the hTERT insert from
pWZL-Blast-Flag-HA-hTERT, using the XhoI/SalI restriction sites and subsequent re-ligation.
We then transfected either 106 HONE-1, AGS or HEK293 cells with the hTERT-, DNhTERT
or the empty vector (later referred as HONE-1, AGS or HEK293-EV,-hT and-DN), respective-
ly, using Metafectene and 2 days post transfection we selected for resistant cells and maintained
the cells with the addition of 10 μg/ml Blasticidin (InvivoGen) to the normal growth medium
to establish stable cell lines.
Gene expression analysis by RT-qPCR
Gene expression was determined by quantitative reverse transcription polymerase chain reac-
tion (RT-qPCR) using specific primers and probes for the housekeeping geneHMBS, the non-
coding EBV encoded RNA EBER1, the latency associated EBV genes EBNA1, EBNA2, LMP1
and LMP2A and for the two genes related to the lytic replication cycle of EBV, BZLF1 and
BXLF2, as described earlier [53–55]. Additionally, to detect BZLF1 gene expression in rM81 in-
fected cells we used a different forward primer for the BZLF1 (5’-CAC GAC GTA CAA GGA
AAC-3’) and LMP1 (5’-TGG AGG CCT TGG TCT ACT CCT-3’) primer/probe set, which we
termed aBZLF1 and aLMP1, respectively, due to the sequence homology to the Akata EBV
strain. Gene expression of BARF1 was determined using the forward primer 5’-GAG CCT
CTC TGT TGC TGT TG-3’, the probe 5’-FAM-TCC CAA CGC AGG TCA CTG GC-BHQ1-
3’ and the reverse primer 5’-GGG CTT CCT CCT TGT CAT T-3’. Gene expression of hTERT
and DNhTERT was determined using a pre-validated primer/probe assay (Hs00972656;
Applied Biosystems). Therefore, total RNA was isolated at the indicated hours or days, re-
spectively, post inoculation (hpi and dpi, respectively) using the RNeasy Mini Kit (Qiagen,
Hombrechtikon, Switzerland), followed by DNase treatment (DNA-free Kit; Ambion, Zug,
Switzerland) and cDNA synthesis from 0.5 μg RNA using a High Capacity cDNA Reverse
Transcription Kit (Applied Biosystems) according to manufacturers instructions. All reactions
were performed in triplicates for each condition and gene on an ABI Prism 7700 real-time
PCR machine (Applied Biosystems). Results were analyzed with the software SDSv2.3 (Applied
Biosystems) and gene expression was calculated relative to the housekeeping geneHMBS using
the 2^-dCt method. Cycle threshold (Ct) values from technical replicates with standard devia-
tions (SD)> 0.5 were excluded from gene expression calculations. Cts above 36, resulting in
relative gene expression levels below 0.001, defined the limit of detection since most of these
values became unreliable above this threshold regarding their SD.
Western Blot analysis
To determine Telomerase protein levels by western blot, whole-cell extracts were prepared
from 106 cells using RIPA buffer (50 mM Tris-Cl, pH 6.8, 100 mMNaCl, 1% Triton X-100,
0.1% sodium dodecyl sulfate) supplemented with complete mini protease inhibitor cocktail
(Roche, Rotkreuz, Switzerland). After determination of the protein concentration using the
Pierce BCA Protein Assay Kit (Thermo Scientific, Wohlen, Switzerland), protein extracts were
separated on 4–12% NuPAGE Bis-Tris Precast gels (Invitrogen, Zug, Switzerland) and proteins
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were semi-dry transferred for 45 min with 25 V on nitrocellulose membranes (Optitran
BA-S83; Whatman, Wohlen, Switzerland). hTERT and DNhTERT protein were probed with
the primary Telomerase reverse Transcriptase antibody Y182 (1:500; Novus Biologicals, Lu-
zern, Switzerland) and as loading control β-Actin was probed with the primary β-Actin anti-
body (dilution 1:5000; #4967, Cell Signaling, Allschwil, Switzerland). Primary antibodies were
detected using a horseradish peroxidase-conjugated goat anti-rabbit IgG (dilution 1:5000;
#7074, Cell Signaling). Signals were obtained by incubation with the SuperSignal West Femto
Chemiluminescent Substrate (Thermo Scientific) following manufacturer instructions and vi-
sualized on the Image Reader LAS-3000 (Fujifilm, Tokyo, Japan).
Telomeric repeat amplification protocol (TRAP) assay
Telomerase activity was determined using the TRAPeze Telomerase Detection Kit (S7700;
Millipore, Zug, Switzerland) following manufacturers instructions with following modifica-
tions. Protein concentrations were determined using the Pierce BCA Protein Assay Kit
(Thermo Scientific). The reactions were carried out with 1:50 diluted cell lysates, correspond-
ing to 100 cells. Telomerase extension reaction was performed at 30°C for 30 min followed by
2 min denaturation at 94°C and addition of 2 units Taq Polymerase per reaction. Amplification
of the telomeric repeats was done in 30 cycles including denaturation at 94°C for 5 s, annealing
at 55°C for 30 s, elongation at 72°C for 1 min and a final single-step elongation at 72°C for
5 min. TRAP reactions were separated on 10% TBE gels (Invitrogen) and products were visual-
ized after staining with SYBR Green I nucleic acid gel stain, according to manufacturers in-
structions (Sigma-Aldrich) using the GeneFlash gel documentation system (Syngene, Châtel-
St-Denis, Switzerland).
Direct inoculation of epithelial cells with cell-free virus by spinoculation
For the direct inoculation of epithelial cells with cell-free virus or concentrated virus we em-
ployed an adapted spinoculation protocol to achieve measurable frequencies of infection [54].
Briefly, 105 cells were seeded in 12-well plates and incubated over night at 37°C with 5% CO2.
Target cells were then inoculated by adding cell-free virus supernatant or concentrated virus
with varying MOIs, as indicated, to the target cells in a total volume of 500 μl to ensure equal
virus concentrations. Then cells were centrifuged for 1 h at 32°C with 800 × g, supernatant was
aspirated, replaced by 1 ml fresh medium and incubated at 37°C with 5% CO2. To determine
infection frequencies at the indicated hpi or dpi, cells were detached using 0.25% Trypsin-
EDTA (Gibco), washed with 1x phosphate buffered saline (PBS; Gibco), stained with the cell
viability dye 7-Amino-Actinomycin D (7-AAD; BD Bioscience, Allschwil, Switzerland), to ex-
clude non-viable cells, according to manufacturer’s instructions, washed again with 1x PBS
and the amount of GFP positive (GFP+; infected cells) was determined by flow cytometry
using the FACS Canto II (BD Bioscience) within the living cell population. Mock inoculations
of each cell line were performed without virus and the amount of false GFP+ cells, detected as
background signals, were subtracted from corresponding inoculations.
Detection of EBV infected cells by fluorescence in situ hybridization
(FISH)
To validate and confirm infection of AGS cells, EBER-FISH was performed using DIG-labeled
probes specific for EBERs (PanPath, Budel, Netherlands). Hybridization was performed ac-
cording to the manufacturer’s instructions. Briefly, inoculated cells were seeded on microscopy
chamber slides (BD Falcon CultureSlides, BD Bioscience). At the indicated time points cells
were fixed with 4% Roti-Histofix (Carl Roth AG, Arlesheim, Switzerland) for 15 min at room
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temperature (RT), washed with 1x PBS, rinsed with ddH2O and dehydrated in 100% EtOH.
Subsequently, cells were hybridized with the EBER-probes for 2 h at 37°C in a moist environ-
ment. Slides were then washed with 1x PBS and incubated with the secondary Dylight594-la-
beled anti-Digoxigenin antibody (Vector Laboratories, RECATOLAB, S.A., Servion,
Switzerland) for 30 min at RT, washed again with 1x PBS and rinsed with ddH2O. After remov-
ing most of the remaining liquid, slides were mounted with VECTASHIELD Mounting Medi-
um (Vector Laboratories) containing 4’,6-diamidino-2-phenylindole (DAPI) to counterstain
the nucleus. Slides were analyzed using a fluorescence microscope Axioskop 2 MOT plus (Carl
Zeiss, Jena, Germany) and images were process with the AxioVision Rel. 4.8.2 software (Carl
Zeiss).
Statistical analysis
Data sets were tested for statistical significance as indicated using Prism6 (GraphPad, La Jolla,
CA, USA) and P values<0.05 were regarded as statistically significant.
Results
Generation of epithelial cell lines with increased telomerase expression
or expression of the dominant negative telomerase mutant
To address the question whether hTERT expression level influences EBV infection in epithelial
cells, we set out to establish an in vitromodel. For this we chose three EBV-negative epithelial
cell lines: HONE-1, which originates from an EBV-positive NPC but lost EBV in vitro [20,21],
suggesting that they do no longer support EBV infection; the gastric carcinoma cell line AGS,
which is often used to study epithelial cell infection with EBV [5,11,19,56]; and HEK293, deriv-
ing from human epithelial kidney and thus anatomically remote from the oropharynx [43].
The cell lines were stably transfected either with hTERT (hT), the rate limiting component of
the human telomerase complex, the telomerase reverse transcriptase, or its catalytically inactive
mutant DNhTERT (DN) [52]. Empty vector (EV) transfected cells served as control. To con-
firm overexpression in hTERT- and DNhTERT-transfected cells, we investigated gene and pro-
tein expression (Fig 1A and 1B). Compared to EV control cells, we observed increased hTERT
and DNhTERT expression in HONE-1 cells by 92.9 ± 13.1 and 106.0 ± 30.2 fold, respectively;
in AGS cells 20.9 ± 4.7 and 25.7 ± 9.1 fold, respectively; and in HEK293 cells 162.7 ± 28.8 and
153.3 ± 31.8, respectively (Fig 1A). Western blot analysis (Fig 1B) confirmed increased protein
expression of hTERT and DNhTERT in HONE-1, AGS, and HEK293 cells.
Next, we asked how overexpression of hTERT and DNhTERT impacts on telomerase activi-
ty by using the Telomeric Repeat Amplification Protocol (TRAP assay). The assay is a two step
in vitro assay that mimics the in vivo telomerase function, elongation and maintenance of telo-
mere length by synthesis and guidance of 6 base telomeric repeats (TTAGGG) to the 3’ ends of
existing telomeres. In the first step, native, whole-cell protein extract, containing active telome-
rase, is utilized to add telomeric repeats to the 3’ ends of synthetic oligonucleotide substrates
(TS). The second step is the amplification of these extended TRAP products by PCR, thus gen-
erating a ladder of fragments with 6 nucleotide increments, starting at 50 nucleotides, which
then can be separated by polyacrylamide gel electrophoresis. Fig 1C shows a representative re-
sult for HEK293 cells. Endogenous telomerase activity was readily detected in all three EV con-
trol cell lines (Fig 1D). Telomerase activity in AGS-hT and HEK293-hT cells was increased to
195.6% and 255.1, respectively, compared to corresponding EV control cells (Fig 1D). In con-
trast, the ectopic expression of hTERT did not lead to an increase in telomerase activity in
HONE-1-hT cells, instead we detected slightly decreased telomerase activity in HONE-1-hT
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cells (82.9%) compared to the EV controls (Fig 1D). This contrasted the robust increase ob-
served at the gene and protein level (Fig 1A and 1B). The rather moderate change in telomerase
activity in HONE-1-hT cells is in line with findings of Hahn and colleagues [52]. The telome-
rase activity in HONE-1-EV and HEK293-EV cells was 8.8-fold and 6.4-fold, respectively,
whereas that of AGS-EV 1.7-fold in relation to the internal standard control as determined by
TRAP assay. Thus, the relatively high telomerase activity in parental HONE-1 cells might have
impeded additional increase of telomerase activity in HONE-1-hT cells.
The expression of DNhTERT led to suppression of telomerase activity below endogenous
levels in all three cell lines with the strongest reduction of 85.1% observed in HONE-1-DN
cells followed by reduction of 70.7% in HEK293-DN cells and of 21.9% in AGS-DN cells com-
pared to in the respective EV control cells. Nevertheless, we did not observe any obvious sign
of growth inhibition or senescence in DNhTERT-transfected cell lines as observed by Hahn
et al. [52]. All cell lines stably expressing DNhTERT showed a growth behavior in culture simi-
lar to their corresponding controls and hTERT cells. Cell clones with sufficient amounts of
DNhTERT to completely block telomerase activity might indeed stop proliferating, eventually
Fig 1. Increased hTERT/DNhTERT expression and altered telomerase activity in engineered epithelial cell lines. A) hTERT and DNhTERTmRNA
levels were determined in empty vector control (EV; white), in hTERT- (hT; grey) and DNhTERT- (DN; black) overexpressing cells by RT-qPCR relative to
HMBS and shown as fold change over EV. Data is shown as Mean ±SEM of 3 independent experiments. * = p<0.05; ** = p<0.01; *** = p<0.001 (ordinary
one-way ANOVA; Dunnett’s multiple comparison test). B) Protein expression was confirmed by western blot using β-Actin as loading control. Telomerase
activity (T) was determined by TRAP assay (C; representative assay) relative to corresponding standard internal controls (S-IC) in empty vector (EV) control,
in hTERT- (hT) and DNhTERT- (DN) overexpressing cells and shown relative to corresponding EV control cells (D). Data is represented as Mean from
triplicate measurements. PC = positive control; NC = negative control; h.i. = heat inactivated.
doi:10.1371/journal.pone.0123645.g001
EBV in Epithelial Cells
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becoming apoptotic [52], and be lost during the selection procedure. Indeed, we did observe
single cells with the characteristic large and flattened, crisis-associated morphology in the sta-
bly DNhTERT-transfected cell lines, indicating that some cells stopped proliferating.
Taken together, although expression of hTERT protein was significantly increased in all
three stably transfected cell lines, telomerase activity was markedly increased only in AGS-hT
and HEK293-hT cells. The expression of DNhTERT led to consistent marked decrease of telo-
merase activity in all three stably transfected cell lines.
GFP and RNA carryover can be distinguished from de novo expression
As an initial set of experiments we performed inoculation studies to determine the optimal
point in time to analyze the EBV infection in epithelial cells and to prevent an overestimation
of the infection due to carryover of GFP protein and EBV RNA by the virus particles [57] and
by exosomes that might be present in the virus preparation [58] We used a recombinant, proto-
typic EBV strain, rB95.8, that carries a green fluorescent protein (GFP), allowing the identifica-
tion of infected cells by fluorescence [45]. We inoculated HEK293 cells using a spinoculation
protocol [54] at a multiplicity of infection (MOI; given as infectious units/target cell) of 0.5.
The frequencies GFP positive (GFP+) cells were determined by flow cytometry and EBV gene
expression of the non-coding RNA EBER1 and of the immediate-early lytic gene BZLF1 by
RT-RT-qPCR at 1, 24, 48 and 72 hours post inoculation (Fig 2). UV-inactivated rB95.8
(rB95.8-UV) served as control.
One hour post inoculation we detected a shift of the whole cell population towards a higher
GFP fluorescence intensity in cells inoculated with rB95.8 and rB95.8-UV (Fig 2A; upper
panel; 1 hpi), which resulted in 5.14% ± 1.31 and 5.15% ± 1.55 GFP+ cells, respectively. This
amount of GFP+ cells likely reflects binding of viral particles to the cell surface and therefore
carryover of GFP, especially by the UV-inactivated virus. Importantly, this shift was not longer
detected at 48 hpi and 72 hpi (Fig 2A; middle and lower panel, respectively), when we detected
0.37% ± 0.08 and 0.45% ± 0.05 GFP+ cells, respectively in cells inoculated with rB95.8, whereas
cells inoculated with the UV-inactivated virus showed amounts of GFP+ cells at most around
background levels (0.10% ± 0.05 and 0.16% ± 0.08; Fig 2A; middle and lower panel, respective-
ly). Fig 2B shows the compiled results for the infection frequencies after subtraction of the
background signals obtained from mock-inoculated samples. Cells that were inoculated with
rB95.8 showed reduced but stable amounts around 0.5% of GFP+ cells from 24 hpi to 72 hpi.
By contrast, cells inoculated with rB95.8-UV showed almost no GFP+ cells (< 0.2%) within
this early phase after the inoculation and which corresponds to carryover of GFP. Thus, these
results demonstrate that there is a transfer of GFP and EBV RNA by the virus particles to the
target cells but the majority of GFP+ cells 72 hpi is due to de novo synthesis of GFP. Similarly,
we detected EBER1 RNA and BZLF1mRNA 1 hpi with rB95.8 or with UV-inactivated rB95.8
(Fig 2C and 2D, respectively). EBER1 expression reached the lowest level at 24 hpi, was subse-
quently showing an increasing trend and reached initial levels at 72 hpi when cells were inocu-
lated with rB95.8. In rB95.8-UV-inoculated cells, EBER1 levels were initially similar (1 hpi;
p> 0.05) to those in rB95.8-inoculated cells and then they decreased to the lowest levels at 48
hpi but remained unchanged (p> 0.05) from 24 hpi to 72 hpi (Fig 2C). Similar results were ob-
tained for BZLF1. We could detect BZLF1 expression at 1 hpi both in cells inoculated with
rB95.8 or with rB95.8-UV, although it was initially lower in rB95.8-UV-inoculated cells (Fig
2D). While BZLF1 levels decreased between 24 and 72 hpi in rB95.8-inoculated cells, we could
not detect BZLF1 expression in cells that were inoculated with rB95.8-UV between 24 and 72
hpi (Fig 2D). Notably, RNA samples were subjected to DNase treatment to remove any con-
taminating DNA. We cannot, however, exclude carryover of transcripts by virions, which can
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contain various EBV transcripts [59], and exosomes that might co-precipitate during concen-
tration of EBV by centrifugation and may contain EBERs [58]. Nevertheless, our results above
indicate that carryover RNA is quickly degraded and can be distinguished from de novo gene
expression between 24 and 72 hpi.
In summary, we conclude that carryover of GFP and EBV RNA occurs but can be distin-
guished from de novo synthesis and expression at 72 hpi. Therefore, we determined 72 hpi as
optimal time point for further analyses of subsequent inoculation experiments.
Increased hTERT expression and activity positively correlates with the
infection of AGS cells by EBV
After establishment of cell lines stably overexpressing hTERT or DNhTERT and definition of
the optimal time point for the analysis, we investigated the impact of hTERT expression and
telomerase activity on the infection of these epithelial model cell lines. We used the pool of sta-
bly transfected cells and did not select for single cell clones for our experiments. As mentioned
above, we inoculated the epithelial cell lines at varying multiplicities of infection (MOI; given
as infectious units/target cell) and determined the frequencies of GFP positive (GFP+) cells 3
days post inoculation (dpi) by flow cytometry as shown in Fig 3.
There were almost no GFP+ cells (<0.05%) in any of the three stably transfected HONE-1
(EV, hT, or DN) cell lines 3 dpi with EBV (Fig 3A). Thus, since HONE-1-hT do not display in-
creased hTERT activity compared to HONE-1-EV (Fig 1D) a potential positive effect of in-
creased telomerase activity on infection frequency could not be tested here, nor could a
potential negative effect of decreased telomerase activity in HONE-1 cells be assessed, since the
infection frequencies were too low for HONE-1-EV. By contrast, AGS-hT cells showed signifi-
cantly increased frequencies of GFP+ cells compared to AGS-EV control cells using MOIs of
Fig 2. GFP and EBV gene expression early upon inoculation of HEK293 cells with rB95.8. A) HEK293 cells were either mock (without virus) inoculated
or with rB95.8 and UV-inactivated rB95.8 (rB95.8-UV) at a MOI of 0.5 (infectious units/target cell), respectively. The amount of GFP+ cells (shown as
Mean ± SEM of 3 independent inoculations above the SSC/GFP gate) was determined within the living cell (7-AAD negative) population by flow cytometry at
1 hour (upper panel) and 72 hours (lower panel) post infection (hpi). Dot plots show representative samples of triplicates from 3 independent inoculations. B)
HEK293 cells were inoculated and analyzed as mentioned before at the indicated time points post inoculation with rB95.8 (black) or rB95.8-UV (white). The
amount of GFP+ cells is shown after subtraction of the background signal obtained frommock-inoculated cells. Data is represented as Mean ± SEM of 3
independent inoculations. C) EBER1 and D) BZLF1 gene expression was determined at the indicated time points post inoculation with rB95.8 (black) or
rB95.8-UV (white) as mentioned above in HEK293 cells by RT-qPCR relative to HMBS. Data is represented as Mean ± SEM of 3 independent inoculations;
n.d. = not detected; * = p<0.05 (unpaired t test; Holm-Sidak method).
doi:10.1371/journal.pone.0123645.g002
Fig 3. Telomerase dependent EBV infection in stably transfected epithelial cell lines. The amount of infected (in %GFP+ cells) HONE-1 (A), AGS (B)
and HEK293 (C) cell lines was determined within the living cell (7-AAD negative) population by flow cytometry 3 dpi with rB95.8 after subtraction of the
background signal obtained frommock-inoculated cells. Data is represented as Mean ± SEM of 3 independent inoculations. Empty vector (EV) control
cells = white; hTERT (hT) overexpression = grey; DNhTERT (DN) overexpression = black; * = p<0.05; ** = p<0.01; *** = p<0.001; **** = p<0.0001
(ordinary one-way ANOVA; Dunnett’s multiple comparison test).
doi:10.1371/journal.pone.0123645.g003
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0.5 and 1.0 (0.47% ± 0.05 vs. 0.30% ± 0.01; p< 0.05, and 0.46% ± 0.03 vs. 0.20% ± 0.09;
p< 0.01, respectively; Fig 3B). Using MOI 2.5, AGS-hT cells showed a similar frequency of
GFP+ cells compared to AGS-EV cells (2.06% ± 0.16 vs. 2.51% ± 0.33; p> 0.05; Fig 3B), sug-
gesting that the effect of telomerase activity in increasing the frequency of cell infection with
EBV can be overcome by increased numbers of virus particles per cell. The expression of the
dominant negative hTERT mutant and, therefore, the suppression of telomerase activity in
AGS-DN cells correlated with an almost complete absence of infection at MOIs 0.5 (0.02% ±
0.07; p< 0.01) and 1.0 (0.02% ± 0.03; p< 0.05) and with reduction of GFP+ cells at MOI 2.5
compared to in EV control cells (0.55% ± 0.14 vs. 2.51% ± 0.33; p<0.0001; Fig 3D). These re-
sults indicated that the infection of AGS cells by EBV at low MOIs is dependent on telomerase
activity and suggest a contribution of telomerase activity to increased susceptibility to infection
by EBV in these cells.
The frequencies of GFP+ cells in HEK293-EV, HEK293-hT and HEK293-DN cells 3 dpi
with EBV using MOI 0.5 were similar (1.85% ± 0.2, 2.05% ± 0.11 and 2.23% ± 0.19, respective-
ly). This was expected for HEK293-EV and HEK293-hT cells since these cells displayed similar
telomerase activity but it was unexpected for HEK293-DN cells that had clearly lower telome-
rase activity (Fig 1D). Upon EBV inoculation with MOIs 1.0 and 2.5, the frequencies of
GFP+ cells in HEK293-hT cells were increased compared to the EV control cells (3.96% ± 0.09
vs. 2.32% ± 0.12; p< 0.0001 and 10.84% ± 0.93 vs. 7.36% ± 0.54; p< 0.05, respectively). Again
unexpectedly, we observed an increase in the frequencies of GFP+ cells in HEK293-DN cells
compared to HEK293-EV control cells using MOIs 1.0 and 2.5 (3.89% ± 0.19 vs. 2.32% ± 0.12;
p< 0.001 and 9.11% ± 0.49 vs. 7.36% ± 0.54; p< 0.05). These results suggested that reduction
of telomerase activity in HEK293 cells that are not close to the physiological epithelium for
EBV, has opposite effects with respect to EBV infection as in AGS cells that reflect more closely
the physiological conditions for EBV infection.
Taken together, we observed a positive correlation between EBV infection and hTERT ex-
pression and telomerase activity in AGS cells. In HEK293 cells, however, overexpression of
DNhTERT resulted in increased frequencies of GFP+ cells after inoculation with EBV, indicat-
ing that telomerase activity-associated positive effects related to EBV infection of epithelial
cells might be epithelial cell background-specific and therefore the choice of the model system
heavily influences the outcome of the studies.
Increased telomerase activity associates with enhanced EBV gene
expression
Given that it was not possible to assess telomerase activity-dependent effects on EBV infection
in HONE-1 cells we focused our further experiments on AGS and HEK293 cells. Since upon in-
oculation with rB95.8, the expression of GFP is driven by the constitutive CMV promoter [45],
GFP expression is not completely identical with infection of the cells resulting in EBV gene ex-
pression or replication. Therefore, we determined EBV gene expression of the non-coding
RNA EBER1 and BZLF1 as mentioned above and additionally of three latency-associated genes
EBNA1, EBNA2, and LMP1, of BARF1 and of the late lytic gene BXLF2 in AGS cells and
HEK293 cells upon inoculation at MOI 2.5 (Fig 4A and 4B), as these cells had demonstrated
the highest frequencies of GFP+ cells 3 dpi with EBV using this MOI (Fig 3B and 3C). We de-
tected expression of all EBV genes tested in our panel and of EBER1 in all stably transfected
AGS and HEK293 cell lines (Fig 4). The most abundant transcripts were EBNA1 in AGS cells
and EBER1 in HEK293 cells (data not shown). Increased hTERT expression and telomerase ac-
tivity in AGS-hT cells correlated with increased transcription of all EBV genes including
EBER1 with the exception of BZLF1 that was reduced to 0.7-fold, compared to EV control cells
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(Fig 4A). The strongest increases in transcription in AGS-hT cells compared to AGS-EV con-
trol cells were recorded for LMP1 (5.4-fold), BARF1 (4.4-fold), EBNA1 (2.4-fold), and BXLF2
(2.0-fold). Conversely, suppression of telomerase activity in AGS-DN cells resulted in lower or
similar (LMP1) expression of all tested genes compared to EV control cells. Thereby, BZLF1 ex-
pression (0.1-fold) showed significant reduction in AGS-DN in comparison to AGS-EV cells
(Fig 4A). The overexpression of hTERT in HEK293-hT cells led as well to the up-regulation of
all EBV genes tested and LMP1 showed the strongest and most significant up-regulation of
2.7-fold over EV control cells (Fig 4B). Similarly, expression of EBNA1 (1.7-fold), EBNA2
(2.0-fold) and BXLF2 (2.0-fold) were significantly higher in HEK293-hT cells compared to
HEK293-EV cells (Fig 4B). EBV gene expression in HEK293-DN cells was comparable to in
HEK293-EV control cells (Fig 4B), although HEK293-DN cells exhibited reduced telomerase
activity compared to HEK293-EV cells (Fig 1D).
Taken together, these results indicate that the expression of EBV genes is influenced by telo-
merase activity in both AGS and HEK293 cells, since the increase and the reduction of telome-
rase activity resulted in up-regulation and down-regulation of EBV gene expression,
respectively. This, in turn, also suggests that the differences observed between AGS cells and
HEK293 cells with respect to frequencies of GFP+ cells related to telomerase activities after in-
oculation with EBV must not be mirrored in differences of EBV gene expression.
Increased infection frequencies of AGS-hT and decreased infection
frequencies of AGS-DN cells are observed with distinct EBV strains
To confirm and expand our observation that hTERT overexpression associates with increased
infection frequencies, while expression of DNhTERT results in reduced infection frequencies
in AGS cells, we tested two additional EBV strains on the AGS model cell lines that also reflect
are more physiological background for an infection by EBV as mentioned above. Next to
rB95.8, we employed the EBV strain M81 (rM81), which was originally isolated from a Chinese
patient with NPC and that shows an increased epithelial cell tropism as compared to the
Fig 4. Telomerase dependent EBV gene expression in epithelial cells upon infection with rB95.8. EBV gene expression was determined in AGS (A)
and HEK293 (B) empty vector control (EV; white), in hTERT (hT; grey) and in dominant negative hTERT (DN; black) cells, respectively, 3 dpi with rB95.8 at
MOI 2.5 (infectious units/target cell) by RT-qPCR relative to HMBS and shown as fold change over EV control. Data is represented as Mean ± SEM of 3
independent inoculations; * = p<0.05; ** = p<0.01; *** = p<0.001 (ordinary one-way ANOVA; Dunnett’s multiple comparison test).
doi:10.1371/journal.pone.0123645.g004
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prototypic EBV strain B95.8 [44]. The other additional EBV strain was a B95.8-based EBV
with a BZLF1-knockout (rBZLF1-KO) that is not able to undergo lytic replication [46]. The
amount of GFP+ cells was again determined 3 dpi with EBV by flow cytometry.
The control inoculation with the prototypic EBV strain rB95.8 (Fig 5A) showed similar re-
sults compared to previous experiments (Fig 3B). Slightly increased, although not significant,
frequencies of GFP+ cells were detected in AGS-hT (3.50% ± 1.71) as compared to AGS-EV
cells (2.83% ± 0.68), whereas AGS-DN cells showed a reduced amount of GFP+ cells (0.78% ±
0.22) compared to AGS-EV.
Given its increased tropism for epithelial cells, we expected higher frequencies of GFP+ cells
with rM81 EBV. In general, we detected somewhat lower amounts of GFP+ cells (Fig 5B) as we
had seen after inoculation with rB95.8, however, the reasons are not clear. Nevertheless, the
pattern was similar, with higher frequencies of GFP+ cells in AGS-hT (1.73% ± 0.77) and de-
creased amounts of GFP+ cells in AGS-DN (0.63% ± 0.27) as compared to AGS-EV control
cells (1.40% ± 0.52) (Fig 5B). Interestingly, the inoculation with the rBZLF1-KO virus resulted
overall in about 10-fold higher amounts of GFP+ cells (Fig 5C), again with the same tendency
that AGS-hT showed increased amounts of GFP+ cells (26.90% ± 2.45) and AGS-DN lower
frequencies of GFP+ cells (15.13% ± 1.70) as compared to AGS-EV cells (18.43% ± 2.78).
Taken together, inoculations with all three virus strains resulted in increased amounts of
GFP+ AGS-hT cells and decreased frequencies of GFP+ AGS-DN cells as compared to the
amount of GFP+ cells in AGS-EV. The much higher frequencies of GFP+ cells obtained with
the rBZLF1-KO virus could be explained by the fact that there is no BZLF1mRNA expression
contrasting the rB95.8 and the rM81 strains (Fig 6A–6C: 3dpi), suggesting lytic replication in
the latter and loss of infected cells through subsequent lysis.
To further verify EBV infection in these cells we performed fluorescence in situ hybridiza-
tion (FISH) experiments to detect EBER expressing cells 3 dpi as shown in Fig 6A. Infected epi-
thelial cells might actually lose GFP expression, which would lead to an underestimation of the
infection, especially upon inoculation with rM81. Surprisingly, at 3 dpi with rB95.8 we found
only GFP+ cells and cells without or at most with very low EBER expression (Fig 7A; left
panel). In contrast, at 3 dpi with rM81 (Fig 7; middle panel) and rBZLF1-KO virus, (Fig 7;
right panel), respectively, almost all infected cells appeared to be double positive for GFP and
EBER1 (GFP+/EBER+). Notably, especially cells with strong GFP expression were clearly
EBER positive, indicating that either more virus per cell entered or that GFP expression from
this recombinant virus is more efficient since it does not undergo lytic replication which would
lead to loss of infected cells by cell lysis. When AGS-DN cells were inoculated with rM81 or
rBZLF1-KO virus about half of the infected cells were positive only for EBER and did not show
any GFP expression or only very low (Fig 7; lower middle and lower right panel). This sug-
gested additionally that hTERT might influence GFP expression from the CMV promoter of
these recombinant viruses. In summary, we might actually overestimate the infection frequen-
cies as determined by flow cytometry for the infections with rB95.8 and underestimate the in-
fection frequencies for the other two viruses.
Next, we determined EBV gene expression as described above to confirm an ongoing infec-
tion within the cells 3 dpi. Notably, we did DNAse treatment of the samples to prevent detec-
tion of contaminating DNA including unspliced BZLF1 DNA. Moreover, we ascertained that
LMP2AmRNA from rM81 virus is detected very well by our RT-qPCR assay. Overall EBV
gene expression levels were lower (Fig 6A–6C) compared to the previous experiments (Fig 4).
Nevertheless, 3 dpi with EBV we detected transcription of all tested genes upon inoculation
with rB95.8 except LMP2A and BARF1 (Fig 6A), while we could not detect LMP2A expression
upon inoculation with rM81 (Fig 6B) and, as expected, no BZLF1 expression upon inoculation
with rBZLF1-KO (Fig 6C). Upon inoculation with rB95.8, expression of the latency genes
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EBNA1 and LMP1 and the lytic genes BZLF1 and BXLF2 was increased in AGS-hT cells com-
pared to AGS-EV control cells (Fig 6A). At the same time, expression of EBER1 and EBNA1
was reduced and of BXLF2 absent in AGS-DN cells upon inoculation with rB95.8 (Fig 6A).
Fig 5. Infection frequencies of AGS cell lines upon infection with different EBV strains. The amount of infected (%GFP+) AGS-EV (empty vector
control; white), AGS-hT (hTERT overexpression; grey) and AGS-DN (DNhTERT overexpression; black) cells was determined within the living cell (7-AAD
negative) population by flow cytometry 3 (A-C), 7 (D-F) and 14 (G-I) dpi with rB95.8 (A, D, G), rM81 (B, E, H) and rBZLF1-KO (C, F, I) after subtraction of the
background signal obtained frommock-inoculated cells. Data is represented as Mean ± SEM of 3 independent inoculations.
doi:10.1371/journal.pone.0123645.g005
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Expression of LMP2A and BARF1 was not present in all three cell lines (Fig 6A). AGS-hT and
AGS-DN cells inoculated with rM81 showed reduced or absent expression of all genes tested,
except for BZLF1 that showed increased expression compared to AGS-EV cells (Fig 6B). AGS-
hT cells inoculated with rBZLF1-KO showed increased expression of EBNA1, BARF1 and in-
terestingly BXLF2, while the expression of all EBV genes tested was reduced or even absent in
AGS-DN cells compared to AGS-EV cells (Fig 6C). Expression of BXLF2 in the absence of
BZLF1 indicates that BXLF2 expression might be regulated by other factors, e.g. BRLF1 or del-
taNp63, as is the case for BARF1 [60,61].
In summary, the trend of an increased, telomerase-related EBV gene expression in AGS was
confirmed at 3 dpi using two additional EBV strains.
Loss of GFP expression does not necessarily correlate with loss of EBV
To confirm that increased hTERT expression and telomerase activity in AGS cells can contrib-
ute to the establishment of the EBV infection and assess if they support EBV maintenance
Fig 6. EBV gene expression in AGS cell lines upon inoculation with rB95.8, rM81 and rBZLF1-KO. EBV gene expression was determined in AGS
empty vector control (EV; white), in hTERT (hT; grey) and in dominant negative hTERT (DN; black) cells, respectively, 3 (A-C), 7 (D-F) and 14 dpi (G-I) with
rB95.8 (A, D, G), rM81 (B, E, H) and rBZLF1-KO (C, F, I) by RT-qPCR relative to HMBS. Data is represented as Mean ± SEM of 3 independent inoculations;
n.d. = not detected.
doi:10.1371/journal.pone.0123645.g006
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within these epithelial cells, the infection was followed for additional 14 days by flow cytometry
(Fig 5D–5I), EBER-FISH (Fig 7B and 7C), RT-qPCR (Fig 6D–6I).
Table 1 summarizes the main findings from Figs 5–7. Following inoculation with rB95.8
GFP expression was lost very rapidly, dropping below 0.5% GFP+ cells at 7 dpi and below
0.06% at 14 dpi (Fig 5D and 5G). Similar results were obtained following inoculation with
rM81 (Fig 5E and 5H) although higher numbers of GFP+ AGS-hT cells (0.42% ± 0.16) were
detected 7 dpi compared to AGS-EV cells (0.23% ± 0.09) (Fig 5E). Cells inoculated with
rBZLF1-KO (Fig 5F and 5I) showed the highest frequencies of GFP+ cells in AGS-hT (4.01% ±
0.66; p = 0.0271) that were significantly increased 7 dpi compared to EV-control cells (1.91% ±
0.39) (Fig 5F). However, the amount of GFP+ cells following inoculation with rBZLF1-KO
dropped as well below 0.4% 14 dpi (Fig 5I). Interestingly, AGS-DN cells showed still the lowest
frequencies of GFP+ cells at 7 dpi compared to EV-control cells (Fig 5D–5F), while 14 dpi this
was only the case for rBZLF1-KO inoculated AGS-DN cells (Fig 5I).
EBER-FISH experiments 7 dpi and 14 dpi (Fig 7B and 7C) revealed that in cells inoculated
with rB95.8 almost no GFP+ and/or EBER+ cells were detected 7 dpi except of very few cells in
AGS-EV (Fig 7B, upper left panel) and that rB95.8 or at least GFP and EBER expression was
completely lost 14 dpi (Fig 7C; left panel). In contrast, EBER+ cells were detected in all stably
transfected AGS cell lines inoculated with rM81 (Fig 7B, middle panel) but GFP+ cells were de-
tected only in AGS-hT 7 dpi (Fig 7B; middle panel). GFP expression was as well completely
lost 14 dpi upon infection with rM81 (Fig 7C; middle panel). As expected from the flow cytom-
etry data, GFP+ cells were detected in EBER-FISH assays 7 dpi and 14 dpi with rBZLF1-KO
(Fig 7B and 7C; right panel). However, also cells that were either GFP+ or EBER+ were de-
tected. Especially for AGS-DN cells 7 dpi more EBER+ then GFP+ or double positive cells
were detected (Fig 7B; lower right panel). As shown for the inoculations with rM81, mostly
EBER+ and only few double positive cells were detected 14 dpi with rBZLF1-KO (Fig 7C; right
panel).
Fig 7. Detection of EBV-infected AGS cells by EBER-FISH upon infection with rB95.8, rM81 and rBZLF1-KO. Infection of AGS-EV (empty vector
control), AGS-hT (hTERT-overexpression) and AGS-DN (DNhTERT-overexpression) cells was confirmed by EBER-FISH 3 (A), 7 (B) and 14 (C) dpi. Nuclei
are stained with DAPI (blue). GFP expressing cells appear green, EBER expressing cells appear red and double positive cells appear with yellow nuclei in
merged pictures. Pictures shown are representative for three independent experiments; Scale bar = 50 μm.
doi:10.1371/journal.pone.0123645.g007
Table 1. Summary of main findings from Figs 5–7.
Figure Factor analyzed Days post
inoculation
EBV strain
rB95.8 rM81 rB95.8-BZLF1-KO
5 Frequency of GFP
+ cells
3 ++ ++ +++
7 + + ++
14 - - +
6 GFP / EBER
expression
3 + / (+) + / + + / +
7 (+) / - (+) / + + / +
14 - / - - / + (+) / +
7 Gene expression 3 + (EBER1, EBNA1, LMP1,
BZLF1, BXLF2)
+ (EBER1, EBNA1, LMP1,
BARF1, BZLF1, BXLF2)
+ (EBER1, EBNA1, LMP1,
BARF1, BXLF2)
7 (+) (BZLF1) + (EBER1, BZLF1) + (EBER1, EBNA1)
14 (+)(EBER1) + (EBER1, BZLF1) (+) (EBER1)
- = no expression or not detected; (+) = barely expressed or not in all cell lines detected; + = expressed.
doi:10.1371/journal.pone.0123645.t001
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Similar to the flow cytometry data in Fig 5 we detected decreasing EBV gene expression lev-
els over time (Fig 6). When cells were infected with rB95.8, almost no expression of EBV genes
was detected 7 and 14 dpi (Fig 6D and 6G). Only LMP1 in AGS-hT, BZLF1 in all AGS cell lines
was detected 7 dpi (Fig 6D), while expression of EBER1 was detected in AGS-hT cells 14 dpi
(Fig 6G). All remaining tested genes were not detected or barely reached the limit of detection.
Cells infected with rM81, showed reduced expression of EBER1, EBNA1 and BXLF2 7 dpi,
while BARF1 expression was lost completely and LMP1 as well as LMP2A were not detected
(Fig 6E). The expression of EBER1 was further reduced 14 dpi with rM81 and EBNA1 and
BXLF2 were not detected anymore (Fig 6H). Interestingly, BZLF1 expression was detected in
rM81-inoculated cells at all three time points with more or less unchanged levels (Fig 6B, 6E
and 6H). In rBZLF1-KO-inoculated cells the expression of EBV genes was also lost or reduced
over time (Fig 6C, 6F and 6I). While expression of EBER1 in all three AGS cell lines and
EBNA1 in AGS-EV and AGS-hT was still detected 7 dpi (Fig 6F), only EBER1 could be detected
weakly at 14 dpi (Fig 6I). The expression levels of the remaining EBV genes, tested in our
panel, barely reached the limit of detection or were not detected at all.
Taken together, these results indicate that determining infection frequencies by flow cytom-
etry on the basis of GFP expression gives a good correlation for short-term infections (3 dpi)
with the three virus strains tested, but might become unreliable especially for rM81 and
rBZLF1-KO as shown by EBER-FISH. However, because of the more qualitative nature of the
EBER-FISH assays and the low EBV gene expression levels we can only confirm a contribution
of hTERT expression and telomerase activity to the establishment of an EBV infection 3 dpi.
Nevertheless, these results indicated that lymphotropic EBV strains such as B95.8 can establish
an infection and be maintained in AGS cells only when lytic replication is impaired, while EBV
strains with increased epithelial tropism like M81 can readily do so.
Discussion
In this study we investigate the impact of hTERT expression and telomerase activity on the in-
fection frequency of epithelial cells by EBV in vitro and how infection develops over time. We
found that increased telomerase activity contributes to enhancing EBV infection of AGS cells
within 3 dpi by generating an environment that facilitates EBV’s gene expression in cells over-
expressing hTERT. Moreover, we found that infection frequency of AGS cells by EBV was
influenced by telomerase activity in a distinct way compared to HEK293 cells, suggesting a de-
cisive role of the cellular background. On the other hand, in HONE-1 cells the high endoge-
nous hTERT levels proved cells to become largely refractory to EBV. Our results indicate that
infection of epithelial cells by EBV is a very selective process involving among others telome-
rase activity and cellular background.
Our observation that increased telomerase activity associates with enhanced EBV gene ex-
pression in AGS cells in the first 72 hours after inoculation with the virus is unprecedented. Im-
portantly, we observed enhanced EBV gene expression in AGS-hT cells and conversely
reduced expression in AGS-DN cells using three EBV strains including a lymphotropic, an
epitheliotropic and a replication incompetent strain. Thus, experiments on hTERT gain and
loss of function clearly documented the functional link between telomerase activity and the
magnitude of EBV genes expression in AGS cells using as well distinct EBV strains (Figs 4 and
7; 3 dpi). Moreover, we observed an augmented infection frequency with lower MOIs in AGS-
hT cells. Thus, increased telomerase activity enhances the frequency of AGS cell infection with
EBV that becomes detectable after exposure to low virus titers compared to cells with markedly
less telomerase activity. These results suggest a contribution of telomerase activity in AGS cells
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to either increased susceptibility to infection via factors influencing binding, entry, nuclear
translocation, circularization, DNA replication, assembly or maturation.
A remarkable finding was that despite detection of latent EBV gene expression in the first
72 hours following EBV inoculation latency was not established in AGS cells. We detected ex-
pression of EBNA2, i.e. the latent master regulatory EBV gene [62–65], EBNA1 the latent EBV
gene responsible for mitotic segregation and maintenance of the virus episome [66–69], and
the oncogenic latent EBV gene LMP1 plus the epithelial-specific latent BARF1. Nevertheless,
we did not detect expression of LMP2A, suggesting that EBNA2 expression did not ignite
LMP2A expression as observed in B cells [62,63]. Our findings are in line with those of Shan-
non-Lowe et al. [19] who compared EBV gene expression in epithelial cells to that in B cells
after in vitro EBV inoculation. They found that only a minority of EBV-infected epithelial cells,
as documented by EBER detection, expressed EBNA1 and that EBNA1 in epithelial cells exclu-
sively originated from Qp promoter contrasting to EBNA1 in newly infected B cells that origi-
nated from Cp/Wp promoters. Our results also confirm that EBV is lost from epithelial cells
during prolonged culture [19]. Our data suggest that, although EBV is capable to bind and
enter into AGS cells and even induce expression of important latency-associated viral genes,
the establishment of stable viral persistence in AGS is not achieved, which may be due to the
lack of appropriate adapter molecules to link EBV gene products into host signaling pathways,
as occurs in B-cells.
The detection of the master regulatory lytic gene BZLF1 and of the late lytic gene BXLF2
suggested induction and completion of the viral lytic cycle in EBV inoculated AGS cells. Several
investigators have reported expression of BZLF1 [1,2,19,47,70–74] but not expression of
BXLF2. Our findings on lytic EBV gene expression in AGS cells contrast those in B cells with
respect to hTERT expression. Indeed, hTERT silencing leads to increased BZLF1 gene expres-
sion and hTERT expression inhibits lytic EBV replication in B cells [40,41]. Despite detectable
expression of BXLF2 in AGS cells, we could not detect EBV particle production. The likely rea-
son for this might be that since the maximal infection frequency of both replication-competent
EBV strains used here ranged between 2% to 5%, newly formed EBV particles might have es-
caped detection. An alternative explanation might be that the majority of virus is undergoing
an abortive replication, as it was reported to occur by Strong and colleagues [75]. Notably, rep-
lication of EBV in epithelial cells, however, seems to be important for host-to-host transmis-
sion of the virus as epithelial cell-derived EBV is more lymphotropic than B cell derived [11].
Furthermore, there is some evidence that oropharyngeal epithelium may act as an amplifier for
EBV shed into saliva [5]. Thus, EBV seems to have evolved to exploit B cells as reservoir within
the host and utilizes only selected epithelial cells to facilitate host-to-host transmission.
Inoculation of stably transfected HEK293 cells with EBV revealed a quite discordant infec-
tion pattern in relation to telomerase activity compared to that observed in stably transfected
AGS cells. We observed higher expression of BZLF1HEK293-DN compared to in HEK-
293-EV cells, thus contrasting the findings in the corresponding AGS cells. Shannon-Lowe and
colleagues also noted distinct EBV gene expression in primary epithelial cells, AdAH cells, and
AGS cells [19]. HEK293 cells originate from kidney epithelium, suggesting that telomerase ac-
tivity may affect EBV infection in an opposite way if they originate from an anatomical location
remote from the portal of entry and exit of EBV. Since HONE-1 cells originate from the oro-
pharynx one might expect them to exhibit a similar behavior to AGS cells. We could not in-
crease telomerase activity in HONE-1 cells most likely due to the relatively high telomerase
basal activity compared to in AGS cells. Nevertheless, infection of HONE-1 cells was not possi-
ble in our experimental setup. Since HONE-1 lost EBV in vitro [20] the lack of infection after
inoculation with EBV here despite the relatively high baseline telomerase activity may suggest
that the cells are resistant to infection by free EBV particles. Interestingly, Tsang and colleagues
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[24] showed infection of HONE-1 cells by cell-to-cell contact with lytically induced EBV posi-
tive BL cells, indicating for HONE-1 cells a distinct mode of infection.
A limitation of our study is that we used transformed cells and not primary epithelial cells.
The vast majority of cancer cell lines have to some extent an increased telomerase activity,
which is a hallmark of cancer [76,77]. This is also the case for our epithelial model cell lines,
since hTERT was already endogenously expressed and telomerase activity was detectable.
However, we are convinced that at least the cell line AGS is suitable to study the impact of telo-
merase activity on the infection of epithelial cells since they have a relatively low endogenous
telomerase activity compared to the other epithelial cell lines used here. Interestingly, this is re-
flected by immunohistochemical studies on oro-nasopharyngeal and tonsillar tissues, which
demonstrated that replicating EBV can only rarely be detected in epithelial cells, except in the
case of oral hairy leukoplakia [1,2,78,79].
Our data from the AGS cells indicate that telomerase activity is critical for enhancing EBV
latent genes. In vivo this would be relevant only in basal cells of nasopharyngeal and gastric epi-
thelia since telomerase activity is mostly restricted to these cells. It is possible that in vivo EBV
infection and expression of latent genes in the basal cells could be substantially increased by tel-
omerase activity. This may play a critical role in initiation of EBV-associated neoplastic pro-
cesses in the nasopharyngeal and gastric epithelia. Indeed, EBV infection of basal cells was
hypothesized recently [80]. Our findings contribute to this notion that EBV might infect basal
epithelial cells with increased telomerase activity, probably via cell-to-cell contact. These epi-
thelial cells are then able to support a short-lived infection by EBV. Subsequent differentiation
of infected basal epithelial cells could then potentially facilitate lytic EBV replication. Such rep-
lication might not be so critical for the development of malignancy but may be important in
production of progeny virus that is shed into saliva for host-to-host transmission. Finally, our
findings may contribute to the current hypothesis that, when additional factors are involved,
e.g. telomerase deregulation, allelic deletions, genetic and epigenetic alteration or dysregulated
cell signaling pathways, as seen in NPC [23,30,56,81–85], EBV may be able to infect and estab-
lish an infection in epithelial cells.
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